• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Search 
    •   QMRO Home
    • Blizard Institute
    • Search
    •   QMRO Home
    • Blizard Institute
    • Search
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CommunityBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Discover

    Author
    Prendergast, AJ (16)
    Ntozini, R (11)Chasekwa, B (10)Humphrey, JH (10)Mutasa, K (9)Govha, M (7)Rukobo, S (7)Evans, C (6)Majo, FD (5)Carmolli, MP (4)... View MoreSubject
    Africa (16)
    HIV (8)inflammation (5)immune activation (4)mortality (4)children (3)Infants (3)cytomegalovirus (2)Female (2)HIV Infections (2)... View MoreDate Issued2021 (2)2020 (3)2019 (3)2018 (1)2017 (3)2016 (4)
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 16

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV. 

    Fitzgerald, FC; Lhomme, E; Harris, K; Kenny, J; Doyle, R; Kityo, C; Shaw, LP; Abongomera, G; Musiime, V; Cook, A;... (Oxford University Press, 2019-01-01)
    Objective: Immune activation is associated with morbidity and mortality during human immunodeficiency virus (HIV) infection, despite receipt of antiretroviral therapy (ART). We investigated whether microbial translocation ...
    Thumbnail

    Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial. 

    Siika, A; McCabe, L; Bwakura-Dangarembizi, M; Kityo, C; Mallewa, J; Berkley, J; Maitland, K; Griffiths, A; Baleeta, K; Mudzingwa, S;... (Oxford University Press, 2018-03-04)
    Background: Severely immunocompromised human immunodeficiency virus (HIV)-infected individuals have high mortality shortly after starting antiretroviral therapy (ART). We investigated predictors of early mortality and "late ...
    Thumbnail

    Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants 

    Prendergast, AJ; Chasekwa, B; Rukobo, S; Govha, M; Mutasa, K; Ntozini, R; Humphrey, JH (2017-09-15)
    Thumbnail

    The impact of improved water, sanitation and hygiene on oral rotavirus vaccine immunogenicity in Zimbabwean infants: sub-study of a cluster-randomized trial. 

    Church, JA; Rukobo, S; Govha, M; Lee, B; Carmolli, MP; Chasekwa, B; Ntozini, R; Mutasa, K; McNeal, MM; Majo, FD;... (Oxford University Press for the Infectious Diseases Society of America., 2019-02-16)
    BACKGROUND: Oral vaccines have lower efficacy in developing compared to developed countries. Poor water, sanitation and hygiene (WASH) may contribute to reduced oral vaccine immunogenicity. METHODS: We conducted a ...
    Thumbnail

    Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy 

    Prendergast, AJ; Szubert, AJ; Berejena, C; Pimundu, G; Pala, P; Shonhai, A; Musiime, V; Bwakura-Dangarembizi, M; Poulsom, H; Hunter, P;... (Oxford University Press, 2016-05-18)
    Background. Identifying determinants of morbidity and mortality may help target future interventions for human immunodeficiency virus (HIV)–infected children. Methods. CD4+ T-cell count, HIV viral load, and levels of ...
    Thumbnail

    Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants. 

    Church, JA; Rukobo, S; Govha, M; Carmolli, MP; Diehl, SA; Chasekwa, B; Ntozini, R; Mutasa, K; Humphrey, JH; Kirkpatrick, BD;... (2017-11-02)
    It remains uncertain whether HIV-exposed uninfected (HEU) infants have impaired responses to oral vaccines. We performed a cross-sectional study of 6-month-old infants recruited at birth to the ZVITAMBO trial in Zimbabwe ...
    Thumbnail

    Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the preantiretroviral therapy era 

    Evans, C; Chasekwa, B; Ntozini, R; Humphrey, JH; Prendergast, AJ (Lippincott, Williams & Wilkins, 2016-09-24)
    Objectives: To describe the head growth of children according to maternal and child HIV infection status. Design: Longitudinal analysis of head circumference data from 13 647 children followed from birth in the ZVITAMBO ...
    Thumbnail

    Cytomegalovirus Acquisition and Inflammation in Human Immunodeficiency Virus-Exposed Uninfected Zimbabwean Infants 

    Evans, C; Chasekwa, B; Rukobo, S; Govha, M; Mutasa, K; Ntozini, R; Humphrey, JH; Prendergast, AJ (2017-03-01)
    Thumbnail

    HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. 

    Evans, C; Jones, CE; Prendergast, AJ (Elsevier, 2016-03-31)
    The number of infants infected with HIV is declining with the rise in interventions for the elimination of paediatric HIV infection, but the number of uninfected infants exposed to HIV through their HIV-infected mothers ...
    Thumbnail

    The Anti-inflammatory Effects of Cotrimoxazole Prophylaxis for People Living With Human Immunodeficiency Virus in Sub-Saharan Africa. 

    Bourke, CD; Prendergast, AJ (Oxford University Press, 2019-10-23)
    Cotrimoxazole prophylaxis reduces morbidity and mortality among people living with human immunodeficiency virus (HIV) in sub-Saharan Africa, regardless of age, degree of immunosuppression, disease stage, or duration ...
    • 1
    • 2
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.